Moreover, ANOVA analysis confirmed that the level of anti-dsDNA antibody in Gal-9-treated MRL/lpr lupus-prone mice did not increase, whereas the level in PBS-treated mice significantly increased (Figure 5B). The gene discussed is LGALS9; the disease is systemic lupus erythematosus.